Insider Stock Trading History of Lingnau Lutz


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lingnau Lutz since year 2005. The trader's CIK number is 1354179. At the time of this reporting, Lingnau Lutz is the Director of Nektar Therapeutics . (stock ticker symbol NKTR). See this page for all insider trading activities at Nektar Therapeutics .


Stock purchases, sales, and option exercises reported by insider Lingnau Lutz since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-22 NKTR Nektar Therapeutics Sale 5,000 21.97 109,850
2017-07-14 NKTR Nektar Therapeutics Option Ex 30,000 14.26 427,800
2017-07-14 NKTR Nektar Therapeutics Sale 30,000 20.76 622,800
2017-04-07 NKTR Nektar Therapeutics Sale 7,000 20.05 140,350
2017-02-21 NKTR Nektar Therapeutics Option Ex 30,000 5.14 154,200
2017-02-21 NKTR Nektar Therapeutics Sale 30,000 13.08 392,400
2016-09-15 NKTR Nektar Therapeutics Option Ex 15,000 .00 0
2016-09-15 NKTR Nektar Therapeutics Sale 9,000 19.06 171,540
2016-04-25 NKTR Nektar Therapeutics Sale 15,000 16.27 244,050
2016-04-25 NKTR Nektar Therapeutics Option Ex 15,000 8.37 125,549
2016-01-20 NKTR Nektar Therapeutics Option Ex 15,000 5.15 77,250
2016-01-20 NKTR Nektar Therapeutics Sale 15,000 14.51 217,650
2015-10-28 NKTR Nektar Therapeutics Sale 12,500 12.00 150,000
2015-10-28 NKTR Nektar Therapeutics Option Ex 12,500 6.65 83,125
2015-06-15 NKTR Nektar Therapeutics Sale 25,000 11.15 278,750
2015-06-15 NKTR Nektar Therapeutics Option Ex 25,000 6.65 166,250
2014-11-24 NKTR Nektar Therapeutics Option Ex 15,000 8.81 132,150
2014-11-24 NKTR Nektar Therapeutics Sale 15,000 15.02 225,300
2011-03-07 NKTR Nektar Therapeutics Option Ex 10,000 .00 0
2008-11-14 NKTR Nektar Therapeutics Option Ex 5,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lingnau Lutz (Director of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.